Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome

被引:5
作者
Sirinvaravong, Natee [1 ]
Ziccardi, Mary C. Rodriguez [1 ]
Patnaik, Soumya [2 ]
Shah, Mahek [3 ]
Fernandez, Gustavo [4 ]
Aliling, Jose-Nitram [5 ]
Rubin, Alexander [6 ]
机构
[1] Einstein Med Ctr, Dept Med, Philadelphia, PA 19141 USA
[2] Univ Texas Hlth Sci Ctr Houston, Div Cardiol, Houston, TX 77030 USA
[3] Lehigh Valley Healthcare Network, Div Cardiol, Allentown, PA USA
[4] Temple Univ Hosp & Med Sch, Div Pulmonol, Philadelphia, PA 19140 USA
[5] Univ Calif Los Angeles, Div Rheumatol, Los Angeles, CA USA
[6] Penn Heart & Vasc Grp, Div Cardiol, Philadelphia, PA USA
关键词
D O I
10.1093/omcr/omy024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonbacterial thrombotic endocarditis (NBTE) is described in patients with mucin-producing cancers and connective tissue disorders (usually SLE). We report NBTE in the setting of primary antiphospholipid antibody syndrome (APS). A 65-year-old female with APS was incidentally found to have thickened mitral leaflets on transthoracic echocardiogram with no signs of infection. Transesophageal echocardiogram (TEE) showed a mobile mitral mass (1.4 x 0.7 cm) and moderate mitral regurgitation. Differential diagnoses included bacterial endocarditis, NBTE, thrombus or tumor. Given the history of primary APS, the absence of fever and negative blood cultures, NBTE was considered. Low-molecular-weight heparin, hydroxychloroquine and corticosteroid were initiated. Repeat TEE in a week revealed shrinkage of the mass (0.6 x 0.7 cm), indicating an inflammatory nature. Lifelong anticoagulation is indicated regardless of embolism occurrence. Hydroxychloroquine and corticosteroids may have roles in the treatment. Determining and treating the underlying etiology is important.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 34 条
[1]   Non-bacterial thrombotic endocarditis [J].
Asopa, Sanjay ;
Patel, Anish ;
Khan, Omar A. ;
Sharma, Rajan ;
Ohri, Sunil K. .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 32 (05) :696-701
[2]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027
[3]   Non-Bacterial Thrombotic Endocarditis in a Patient with Rheumatoid Arthritis [J].
Choi, Jung-Hye ;
Park, Jeong-Eun ;
Kim, Jang-Young ;
Kang, Taeyoung .
KOREAN CIRCULATION JOURNAL, 2016, 46 (03) :425-428
[4]   Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial [J].
Cohen, Hannah ;
Hunt, Beverley J. ;
Efthymiou, Maria ;
Arachchillage, Deepa R. J. ;
Mackie, Ian J. ;
Clawson, Simon ;
Sylvestre, Yvonne ;
Machin, Samuel J. ;
Bertolaccini, Maria L. ;
Ruiz-Castellano, Maria ;
Muirhead, Nicola ;
Dore, Caroline J. ;
Khamashta, Munther ;
Isenberg, David A. .
Lancet Haematology, 2016, 3 (09) :E426-E436
[5]  
Contractor T, 2013, J HEART VALVE DIS, V22, P36
[6]   A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome [J].
Crowther, MA ;
Ginsberg, JS ;
Julian, J ;
Denburg, J ;
Hirsh, J ;
Douketis, J ;
Laskin, C ;
Fortin, P ;
Anderson, D ;
Kearon, C ;
Clarke, A ;
Geerts, W ;
Forgie, M ;
Green, D ;
Costantini, L ;
Yacura, W ;
Wilson, S ;
Gent, M ;
Kovacs, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) :1133-1138
[7]   Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature [J].
Dufrost, Virginie ;
Risse, Jessie ;
Zuily, Stephane ;
Wahl, Denis .
CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (12)
[8]   Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000 [J].
Eiken, PW ;
Edwards, WD ;
Tazelaar, HD ;
McBane, RD ;
Zehr, KJ .
MAYO CLINIC PROCEEDINGS, 2001, 76 (12) :1204-1212
[9]   A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome [J].
Erkan, D ;
Yazici, Y ;
Peterson, MG ;
Sammaritano, L ;
Lockshin, MD .
RHEUMATOLOGY, 2002, 41 (08) :924-929
[10]   THE COMPARATIVE EFFICACY AND TOXICITY OF 2ND-LINE DRUGS IN RHEUMATOID-ARTHRITIS - RESULTS OF 2 METAANALYSES [J].
FELSON, DT ;
ANDERSON, JJ ;
MEENAN, RF .
ARTHRITIS AND RHEUMATISM, 1990, 33 (10) :1449-1461